3-(2,2,2-trimethylhydrazine)propionate has been researched along with Heart Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drokina, OV; Druk, IV; Dubileĭ, GS; Nechaeva, GI | 1 |
| Gordjushina, V; Isajevs, S; Kalvinsh, I; Klusa, V; Kratovska, A; Pupure, J; Rumaks, J; Svirskis, S; Taivans, I; Viksna, L | 1 |
2 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and Heart Diseases
| Article | Year |
|---|---|
[Clinical experience of application mildronate at recovery treatment of patients with displazia connecting fabric].
Topics: Adult; Asthenia; Cardiovascular Agents; Connective Tissue Diseases; Drug Administration Routes; Drug Monitoring; Exercise Tolerance; Female; Heart Diseases; Heart Function Tests; Humans; Male; Methylhydrazines; Myocardial Contraction; Treatment Outcome | 2014 |
Protection of azidothymidine-induced cardiopathology in mice by mildronate, a mitochondria-targeted drug.
Topics: Animals; Cardiovascular Agents; Disease Models, Animal; Heart Diseases; Methylhydrazines; Mice; Mice, Inbred ICR; Mitochondria; Zidovudine | 2006 |